The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.e

Acute eosinophilic pneumonia (AEP)

Publications

Elbarbry F, Farthing K, Arguello S

Diagnosis and Management of Daptomycin-Induced Acute Eosinophilic Pneumonia: A Case Report.

Innovations in pharmacy. 2024;15(2)

Hassett MR

Daptomycin-induced eosinophilic pneumonia.

JAAPA : official journal of the American Academy of Physician Assistants. 2024;37(4):1-4

Pham TT, Garreau R, Craighero F, Cottin V, Said BB, Goutelle S, Ferry T

Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm.

Open forum infectious diseases. 2022;9(11):ofac577

Abd Algayoum R, Elsherif A, Khan ZH, Roman G

Daptomycin-Induced Eosinophilic Pneumonia Mimicking Multifocal Pneumonia.

Cureus. 2022;14(10):e30521

Raman V, Chaudhary I, Shieh S

Eosinophilic pneumonia: a case of daptomycin induced lung injury.

Journal of community hospital internal medicine perspectives. 2021;11(2):280-285

Storandt MH, Matta A

Acute Eosinophilic Pneumonia: A Rare Complication of Daptomycin Therapy.

Cureus. 2020;12(1):e6803

Bartal C, Sagy I, Barski L

Drug-induced eosinophilic pneumonia: A review of 196 case reports.

Medicine. 2018;97(4):e9688

De Giacomi F, Decker PA, Vassallo R, Ryu JH

Acute Eosinophilic Pneumonia: Correlation of Clinical Characteristics With Underlying Cause.

Chest. 2017;152(2):379-385

Montenegro O, Del Campo R, Del Rio JJ, Ambrós Checa A

[Acute eosinophilic pneumonia secondary to daptomycin].

Enfermedades infecciosas y microbiologia clinica. 2016;34(6):390-1

Patel JJ, Antony A, Herrera M, Lipchik RJ

Daptomycin-induced acute eosinophilic pneumonia.

WMJ : official publication of the State Medical Society of Wisconsin. 2014;113(5):199-201

Chiu SY, Faust AC, Dand HM

Daptomycin-induced eosinophilic pneumonia treated with intravenous corticosteroids.

Journal of pharmacy practice. 2015;28(3):275-9

Yusuf E, Perrottet N, Orasch C, Borens O, Trampuz A

Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection.

Surgical infections. 2014;15(6):834-7

Phillips J, Cardile AP, Patterson TF, Lewis JS 2nd

Daptomycin-induced acute eosinophilic pneumonia: analysis of the current data and illustrative case reports.

Scandinavian journal of infectious diseases. 2013;45(10):804-8

Kim PW, Sorbello AF, Wassel RT, Pham TM, Tonning JM, Nambiar S

Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.

Drug safety. 2012;35(6):447-57

Rether C, Conen A, Grossenbacher M, Albrich WC

A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

Infection. 2011;39(6):583-5

Miller BA, Gray A, Leblanc TW, Sexton DJ, Martin AR, Slama TG

Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010;50(11):e63-8